Beeyond

This topic follows healthcare as a system in transition, from implants, organoids, CAR-T, and aging biology to digital twins, FDA pathways, reimbursement, and French fast-track trials.

A specialist medtech topic centered on PCI, drug-coated balloons, stents, restenosis biology, coatings, and vascular healing. It shows Beeyond’s appetite for device-level evidence.

Autonomous driving, robotaxis, AI, EV competition, China’s rise, and European restructuring make this more than a car feed. It is a topic about mobility under industrial pressure.

The digital health topic connects consumer devices, remote monitoring, prescription digital therapeutics, liability, engagement, and market access. The focus is implementation, not gadgetry.

This topic treats traceability as safety infrastructure. Serialization, DSCSA compliance, RFID, QR codes, recalls, packaging errors, and visual inspection form a practical pharma-manufacturing watchlist.

A strategy topic that keeps Blue Ocean thinking alive through value innovation, non-disruptive growth, first-mover logic, and cross-sector examples.

AR and VR appear here as commercial tools: smart glasses, enterprise ROI, tourism, retail, consumer engagement, and the coming merge with AI.

This oncology topic is tightly focused on glioblastoma and solid-tumor research pathways, with strong attention to CAR-T, CAR-NK, vaccines, organoids, biomaterials, and oncolytic strategies.

The nudges topic bridges behavioral science and practice, especially in health, adherence, hand hygiene, onboarding, gamification, food choices, and the ethics of influence.

Fashion is treated as a technology system: AI try-on, AR retail, digital product passports, RFID, Web3, wearable computing, circularity, and experimental materials.

This topic frames vaping as a public-health and policy controversy, balancing cessation claims with youth addiction, regulation, bans, taxation, and emerging health-risk evidence.

A beauty-tech topic about instrumentation: microneedling, lasers, AI skin analysis, AR retail, tattoos, microbiome science, and medically adjacent cosmetic devices.

This mitral-regurgitation topic follows transcatheter repair and replacement through trials, approvals, first implants, valve-in-valve comparisons, and next-generation valve materials.

Brain-computer interfaces are tracked through clinical use, invasive and non-invasive systems, stroke rehabilitation, neural implants, EEG devices, regulation, and user experience.

This French topic widens innovation into care systems: family caregivers, rights, respite, mental health, aging, teleassistance, peer support, and public policy.

A neurovascular intervention watchlist spanning stroke therapy, thrombectomy, aneurysm devices, stent coatings, trial results, and regulatory or market signals.

Multiple sclerosis is followed through translational science: EBV, genetics, immunology, microbiome, CAR-T, cell therapy, myelin repair, and prevention research.

The telecom topics track AI agents, Starlink, satellite-to-device, 6G skepticism, spectrum, RAN modernization, and telco business-model pressure.

Diabetes is approached through GLP-1 drugs, cardiometabolic risk, glucose monitoring, smart pumps, artificial pancreas systems, adherence, and wound-healing technologies.

Peritoneal dialysis is treated as both clinical therapy and home-care platform, with posts on outcomes, peritonitis, telemonitoring, quality of life, devices, and program building.

Diagnostics are followed where they become portable, non-invasive, wearable, and closer to home: liquid biopsy, biosensors, microfluidics, breath tests, microneedles, and biomarkers.

Microneedles dominate this drug-delivery topic, from dissolving and hydrogel systems to vaccines, autoimmune disease, sensing, diabetic wounds, hypertension, and manufacturing questions.

This niche diabetes topic focuses on metabolic activation therapy, pulsatile insulin, artificial pancreas concepts, complication repair claims, coverage decisions, and skeptical context.